Free Trial
NASDAQ:SURG

SurgePays (SURG) Stock Price, News & Analysis

SurgePays logo
$0.54 0.00 (-0.33%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$0.54 0.00 (-0.64%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About SurgePays Stock (NASDAQ:SURG)

Advanced

Key Stats

Today's Range
$0.51
$0.58
50-Day Range
$0.51
$0.93
52-Week Range
$0.46
$3.45
Volume
141,789 shs
Average Volume
820,576 shs
Market Capitalization
$13.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

SurgePays Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

SURG MarketRank™: 

SurgePays scored higher than 30% of companies evaluated by MarketBeat, and ranked 453rd out of 626 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    SurgePays has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.

  • Upside Potential

    SurgePays has a consensus price target of $5.00, representing about 820.0% upside from its current price of $0.54.

  • Amount of Analyst Coverage

    SurgePays has only been the subject of 2 research reports in the past 90 days.

  • Read more about SurgePays' stock forecast and price target.
  • Earnings Growth

    Earnings for SurgePays are expected to grow in the coming year, from ($0.44) to $0.06 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SurgePays is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SurgePays is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about SurgePays' valuation and earnings.
  • Percentage of Shares Shorted

    7.79% of the float of SurgePays has been sold short.
  • Short Interest Ratio / Days to Cover

    SurgePays has a short interest ratio ("days to cover") of 3.17, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SurgePays has recently increased by 8.94%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    SurgePays does not currently pay a dividend.

  • Dividend Growth

    SurgePays does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for SurgePays this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, SurgePays insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    30.50% of the stock of SurgePays is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    6.94% of the stock of SurgePays is held by institutions.

  • Read more about SurgePays' insider trading history.
Receive SURG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SurgePays and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SURG Stock News Headlines

The chokepoint supplier behind SpaceX's $1.75 trillion empire
When the SpaceX IPO launches, most retail investors will be locked out. The banks, funds, and insiders get in early - while everyone else waits on the sidelines. But one small infrastructure supplier - a critical piece Musk can't scale the Colossus network without - is still trading well under institutional radar. A new briefing reveals the name and ticker at no cost.tc pixel
SurgePays, Inc. Q4 2025 Earnings Call Summary
See More Headlines

SURG Stock Analysis - Frequently Asked Questions

SurgePays' stock was trading at $1.67 at the start of the year. Since then, SURG stock has decreased by 67.5% and is now trading at $0.5435.

SurgePays, Inc. (NASDAQ:SURG) released its quarterly earnings results on Wednesday, November, 12th. The medical equipment provider reported ($0.38) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $0.21. The medical equipment provider had revenue of $18.68 million for the quarter, compared to analysts' expectations of $18.12 million. SurgePays had a negative trailing twelve-month return on equity of 967.32% and a negative net margin of 63.32%.
Read the conference call transcript
.

SurgePays' Board of Directors initiated a stock buyback plan on Tuesday, August 13th 2024, which allows the company to repurchase $5,000,000 in shares, according to EventVestor. This means that the company could purchase up to 14.8% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's leadership believes its stock is undervalued.

SurgePays' top institutional shareholders include Gaddis Premier Wealth Advisors LLC (1.74%). Insiders that own company stock include Kevin Brian Cox, Anthony George Evers, David Allen May and Richard Earl Schurfeld.
View institutional ownership trends
.

Shares of SURG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SurgePays investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Alibaba Group (BABA), Celsius (CELH) and Energy Transfer (ET).

Company Calendar

Last Earnings
11/12/2025
Today
5/07/2026
Next Earnings (Estimated)
5/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
INTERNET SOFTWARE
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SURG
CIK
1392694
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
+820.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$36.07 million
Net Margins
-63.32%
Pretax Margin
-63.32%
Return on Equity
-967.32%
Return on Assets
-241.91%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.38
Quick Ratio
0.37

Sales & Book Value

Annual Sales
$56.96 million
Price / Sales
0.24
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.66) per share
Price / Book
-0.82

Miscellaneous

Outstanding Shares
25,122,000
Free Float
17,460,000
Market Cap
$13.65 million
Optionable
Optionable
Beta
0.32
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:SURG) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners